CDT Equity Inc.

CDT Healthcare Biotechnology

In the quarter to June 2026, EPS grew 98.0% and free cash flow grew 78.9%, each against the same quarter a year earlier.

0.24 0.03 +14.29%
Market cap
$240.0K
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(69.68%) (71.01%) 561.83% 839.05%

+8 more TTM periods

ROA
(55.16%) (57.17%) (796.99%) (351.75%)
ROIC
(21.28%) (21.83%) 0.00% (2,715.06%)
Return on Tangible Assets
183.40% 209.75% 479.98% (643.79%)
Free Cash Flow per Share
(539.15) (4,662.07) (159,600.00) (151,300.00)
Free Cash Flow
(11.48) (13.52) (15.96) (15.13)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Oct 2026